EX-32.1 6 dex321.htm CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 1350 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 1350

Exhibit 32.1

 

CERTIFICATION PURSUANT TO

SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

Pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, as President and Chief Executive Officer of Genome Therapeutics Corp. (the “Company”) does hereby certify that to my knowledge:

 

  1) the Company’s Report on Form 10-Q for the quarter ended September 27, 2003, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  2) the information contained in the Company’s Report on Form 10-Q for the quarter ended September 27, 2003, fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

By:   /s/    Steven M. Rauscher        
 
   

Steven M. Rauscher

President & Chief Executive Officer

   

Dated: November 11, 2003